Guardant Health, Inc.GHNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

28 analysts·High coverage

100%

Rating Distribution

Strong Buy

00%

Buy

28100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 9% higher.

Bear Case

$75.00

-35%

Consensus

$125.00

+9%

Bull Case

$175.00

+52%

Price Range28 analysts

Low

Consensus

High

$75.00

$175.00

Current Target

Current Price

$115.01

Upside to Target

$9.99

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Unable to load analyst estimates

Earnings Surprises

Earnings surprise history unavailable.

Recent Analyst Actions

Jan 30, 2026UBS

Guardant Health price target raised to $175 from $110 at UBS

Target:$175.00

+57.7%from $111.00

Jan 26, 2026Guggenheim

Guardant Health price target raised to $135 from $115 at Guggenheim

Target:$135.00

+16.7%from $115.69

Jan 9, 2026Stifel Nicolaus

Guardant Health price target raised to $120 from $100 at Stifel

Target:$120.00

+10.4%from $108.74

Jan 9, 2026Mizuho Securities

Guardant Health price target raised to $135 from $120 at Mizuho

Target:$135.00

+24.1%from $108.74

Jan 5, 2026Guggenheim

Guardant Health price target raised to $115 from $85 at Guggenheim

Target:$115.00

+16.2%from $99.00

Jan 5, 2026Evercore ISI

Guardant Health downgraded to In Line from Outperform at Evercore ISI

Target:$105.00

+3.2%from $101.74

Dec 22, 2025Canaccord Genuity

Guardant Health price target raised to $125 from $100 at Canaccord

Target:$125.00

+25.3%from $99.74

Dec 17, 2025Mizuho Securities

Guardant Health price target raised to $120 from $100 at Mizuho

Target:$120.00

+20.0%from $100.00

Dec 15, 2025Leerink Partners

Guardant Health price target raised to $155 from $115 at Leerink

Target:$155.00

+49.0%from $104.00

Dec 15, 2025Wells Fargo

Guardant Health price target raised to $120 from $93 at Wells Fargo

Target:$120.00

+17.6%from $102.04

Dec 15, 2025Barclays

Guardant Health price target raised to $120 from $85 at Barclays

Target:$120.00

+17.6%from $102.04

Dec 12, 2025BTIG

Guardant Health price target raised to $140, named 2026 Top Pick at BTIG

Target:$140.00

+38.1%from $101.34

Dec 1, 2025Morgan Stanley

Guardant Health assumed with an Overweight at Morgan Stanley

Target:$130.00

+23.6%from $105.22

Oct 30, 2025UBS

Guardant Health price target raised to $110 from $80 at UBS

Target:$110.00

+15.4%from $95.29

Oct 30, 2025BTIG

Guardant Health price target raised to $100 from $80 at BTIG

Target:$100.00

+4.7%from $95.55

Oct 30, 2025Mizuho Securities

Guardant Health price target raised to $100 from $75 at Mizuho

Target:$100.00

+38.4%from $72.27

Oct 30, 2025Canaccord Genuity

Guardant Health price target raised to $100 from $75 at Canaccord

Target:$100.00

+38.4%from $72.27

Oct 30, 2025Barclays

Guardant Health price target raised to $85 from $70 at Barclays

Target:$85.00

+17.6%from $72.27

Oct 22, 2025Piper Sandler

Guardant Health price target raised to $90 from $60 at Piper Sandler

Target:$90.00

+33.3%from $67.51

Oct 2, 2025Barclays

Guardant Health price target raised to $70 from $60 at Barclays

Target:$70.00

+11.7%from $62.65

Sep 26, 2025Canaccord Genuity

Guardant Health price target raised to $75 from $65 at Canaccord

Target:$75.00

+24.6%from $60.18

Sep 25, 2025Stifel Nicolaus

Guardant Health price target raised to $70 from $60 at Stifel

Target:$70.00

+16.3%from $60.18

Sep 25, 2025BTIG

Guardant Health price target raised to $80 from $70 at BTIG

Target:$80.00

+31.7%from $60.75

Sep 25, 2025Stifel Nicolaus

Guardant Health price target raised to $73 from $60 at Stifel

Target:$73.00

+16.5%from $62.64

Sep 25, 2025Wolfe Research

Wolfe upgrades Guardant to Outperform after 'solid' analyst day

Target:$75.00

+22.5%from $61.23

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance